2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$8.96+$0.04 (+0.51%)
Price as of Jul 14, 2026 4:36 AM EDT- $1.5BMarket Cap
- 27.83%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$8.96+$0.04 (+0.51%)
Earnings Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -1 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 1.66% | ||
12-Month Momentum | 25.15% | ||
3-Month Risk Adjusted Momentum | 5.22% | ||
12-Month Risk Adjusted Momentum | 37.39% |
True Yield
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -3.73% |
Financial Health Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |